
CAC2 Childhood Cancer Community News Digest (July 28-August 3)
Assorted News from the Last Week: Scoping review of the utilization of wearable devices in pediatric and young adult oncology Engineered L-asparaginase variants with enhanced
Assorted News from the Last Week: Scoping review of the utilization of wearable devices in pediatric and young adult oncology Engineered L-asparaginase variants with enhanced
Assorted News from the Last Week: Researchers at the University of Florida are moving closer to developing what they have described as a “universal” cancer
Assorted News from the Last Week: Muscle weakness in cancer survivors may be caused by treatable weakness in blood vessels. An aggressive childhood cancer case
Assorted News from the Last Week: Survival rates for cancer patients on immunotherapy depend on insurance coverage: Those on private insurance or Medicaid had higher survival
Assorted News from the Last Week: CAC2 Guest Blog Post–The National Cancer Institute (NCI) will host the CCDI Symposium this October and bring together the
Assorted News from the Last Week: Nutritional status, body composition, and chemotherapy dosing in children and young people with cancer: a systematic review by the
Assorted News from the Last Week: CAC2 sends childhood cancer survivors a Thank You note. Targeting fusion protein’s role in childhood leukemia produces striking results.
Assorted News from the Last Week: My 5-year-old survived cancer twice. Medical innovation shouldn’t be political. Pediatric patients with diffuse midline gliomas (DMGs) may have
Assorted News from the Last Week: The Global Initiative for Childhood Cancer aims for a two-thirds remission rate by 2030, saving the lives of approximately
Assorted News from the Last Week: Children and young people are waiting longer than necessary for cancer diagnosis, according to new research. Disruptions to school,